Electromedical Technologies, Inc Cash Flow Statement
EMED|4 years of annual SEC 10-K data (FY2020-FY2023)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 4 fiscal years. All figures from audited SEC 10-K filings.
Electromedical Technologies, Inc used $1M in operating cash flow and negative free cash flow of $2M in FY2023.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -40.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|
| Net Income | -$2.6M | -$3.5M | -$8.5M | -$3.9M |
| Depreciation & Amortization | $4.6K | $21.9K | $21.9K | $21.9K |
| Operating Cash Flow | -$1.4M | -$773.3K | -$1.2M | -$1.3M |
| Capital Expenditures | $149.7K | - | - | - |
| Free Cash Flow | -$1.6M | - | - | - |
| FCF Margin | -116.2% | - | - | - |